Take Action

Tell the FDA psychedelic therapy matters

The FDA is holding a public hearing on the future of psychedelic therapy, and it's taking comments from the public right now. Whatever you write becomes part of the official federal record.

Oct 5
Written comments close October 5, 2026 at 11:59 p.m. ET.
What your comment does

The FDA is seeking perspectives on the potential therapeutic use of psychedelic drugs in supervised and supportive settings. Share what you want the agency to consider about research, access and safeguards.

Your comment adds your perspective to the public record. The hearing is an opportunity for input, not a decision to approve a treatment.

The goal: a clear, science-based FDA pathway that gets these therapies to the people who need them - with strong guardrails, and without years of needless delay.

Start your comment

This draft is a starting point. Edit it to reflect your own views and add any experience you choose to share. Comments are public: leave out private information you do not want published.

Submit your comment
  1. Tap Copy above (or write your own).
  2. Hit Submit your comment to open regulations.gov, then paste it in the Comment box.
  3. Complete the form using the category that accurately describes you.
  4. Review your comment, submit it on regulations.gov, and save your confirmation.
Submit your comment →
Docket FDA-2026-N-7542 · written comments due October 5, 2026 at 11:59 p.m. ET.
The hearing is September 14, 12:30–4:30 p.m. ET. Speaking requests have closed. See attendance information →
Portal is an IRS-recognized 501(c)(3) nonprofit (EIN 33-3011832). This is nonpartisan civic-engagement information, not legal advice. Your comment is submitted directly to the U.S. government on regulations.gov - Portal never sees it.

community.youaretheportal.org